Javitt Daniel C. 13D/13G Filings for NRx Pharmaceuticals, Inc. (NRXP)

Javitt Daniel C. 13D and 13G filings for NRx Pharmaceuticals, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2022-09-13
4:47 pm
Purchase
2022-07-0113DNRx Pharmaceuticals, Inc.
NRXP
Javitt Daniel C.987,290
14.600%
987,290increase
(New Position)
Filing